Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-11

Clinical Trial Update: Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users [Phase 4]

View source ↗

Summary

Phase 4 trial assessing extended-release naltrexone with care management for adults with alcohol dependence and high ED utilizers; study completed with posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • extended-release naltrexone (naltrexone)

Snippet

Sponsor: NYU Langone Health | Conditions: Alcohol Dependence, Alcohol Use Disorder | Phase 4 | Status: COMPLETED | Results posted: 2022-05-11